Combivent and Hydrea drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Combivent (albuterol sulfate; ipratropium bromide) and Hydrea (hydroxyurea). Common drug interactions include dyspnoea among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Combivent and Hydrea. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Combivent?

Combivent has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in asthma. eHealthMe is studying from 35,341 Combivent users. Check the latest studies of Combivent.

What is Hydrea?

Hydrea has active ingredients of hydroxyurea. It is often used in polycythemia vera. eHealthMe is studying from 9,083 Hydrea users. Check the latest studies of Hydrea.

On Jul, 10, 2026

18 people who take Combivent and Hydrea together, and have interactions are studied.

What are the common drug interactions of Combivent and Hydrea, by gender? *:

female:

Dyspnoea (difficult or laboured respiration)
Chest pain
Haemoglobin decreased
Headache (pain in head)
Hospitalisation
Influenza
Nausea (feeling of having an urge to vomit)
Pain
Pain in extremity
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

male:

Dyspnoea (difficult or laboured respiration)
Abdominal pain
Cough
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Depression
Diarrhoea
Drug abuser
Drug dependence
Drug ineffective

What are the common drug interactions of Combivent and Hydrea, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chest pain
Dyspnoea (difficult or laboured respiration)
Nausea (feeling of having an urge to vomit)
Pain
Vomiting
Haemoglobin decreased
Headache (pain in head)
Hospitalisation
Influenza
Pain in extremity

50-59:

Cerebral atrophy (decrement in size of brain)
Cerebral disorder (brain disease)
Cerebral infarction (less blood supply to brain resulting tissue damage)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Renal impairment (severely reduced kidney function)
White blood cell count decreased

60+:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Dyspnoea (difficult or laboured respiration)
Gait disturbance
Groin pain
Haematoma (collection of blood outside the blood vessels)
Insomnia (sleeplessness)
International normalised ratio increased
Lip oedema (swelling of lip)
Platelet count increased
Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)

What are the existing conditions these people have? *

Pulmonary Hypertension (increase in blood pressure in the lung artery): 6 people, 33.33%
Thrombocythaemia (an increased number of platelets in the circulating blood): 2 people, 11.11%
Pain: 2 people, 11.11%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 11.11%
Testicular Germ Cell Cancer (germ cell cancer of testes): 1 person, 5.56%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 1 person, 5.56%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 5.56%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 5.56%
Essential Thrombocythaemia (chronic blood cancer): 1 person, 5.56%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Combivent and Hydrea?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously